Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study

Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study

ABSTRACT: Objectives: The aim of this study was to assess the efficacy of dolutegravir plus lamivudine (DTG+3TC) in a large set of virologically suppressed HIV-1 infected individuals with or without past M184V mutation. Methods: This observational study included individuals who switched to DTG+3TC...

Full description

Bibliographic Details
Main Authors: Maria Mercedes Santoro, Daniele Armenia, Elisa Teyssou, José Ramón Santos, Charlotte Charpentier, Sidonie Lambert-Niclot, Andrea Antinori, Christine Katlama, Diane Descamps, Carlo Federico Perno, Vincent Calvez, Roger Paredes, Francesca Ceccherini-Silberstein, Anne Geneviève Marcelin
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
M184V
HIV drug resistance
Dolutegravir
Lamivudine
Virological response
Treatment optimization strategies
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716522001898

Internet

http://www.sciencedirect.com/science/article/pii/S2213716522001898

Similar Items